Ayutara ...

Medical Events & Conferences

Join Medisafe Therapeutics at premier global forums in oncology, radiopharmaceuticals, and precision medicine.

Live Updates • Next Event in 128 Days

Featured Event

World Oncology Forum 2025

📅 March 15–18, 2025 • Vienna, Austria

Leading clinicians present breakthrough data on radioligand therapy (RLT) for advanced prostate cancer, including long-term survival outcomes and novel combination strategies.

Booth #A12 • Keynote: Dr. Elena Martinez on Day 2

Upcoming Events

Connect with our medical affairs team and explore the future of targeted radiotherapeutics.

April 10–13, 2025

ASCO® GU Symposium

Precision medicine and biomarker-driven patient selection in genitourinary oncology.

San Francisco, CA

June 22–25, 2025

SNMMI® Annual Meeting

Latest advancements in PSMA and SSTR targeting for optimized therapeutic efficacy.

Chicago, IL

September 8–11, 2025

JP Morgan Healthcare Conference

Scaling RLT manufacturing and global supply chain innovations.

San Francisco, CA

November 5–8, 2025

European Cancer Congress

Novel radiotherapeutics and combination therapies for refractory solid tumors.

Paris, France

Past Events

Key highlights from our global scientific engagements and clinical presentations.

EANM 2024 – Barcelona

Presented SSTR-targeted RLT outcomes in neuroendocrine tumors (NETs) with 78% progression-free survival at 24 months.

APAC Oncology Forum 2024

Explored synergistic effects of radiopharmaceuticals with PD-1 inhibitors in metastatic settings.

Precision Medicine Summit 2024

Introduced AI-driven biomarker panels for personalized RLT dosing protocols.

Global Cancer Forum 2024

Showcased next-gen actinium-based ligands for castration-resistant prostate cancer.

International Radiopharma Symposium

Announced Phase III trial results and global regulatory pathway updates.

Partner with Innovation

Engage with our medical leadership, explore collaboration opportunities, or schedule a meeting at an upcoming event.